Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population‑Based Study

Rafat Shadmehr, Mehdi Sharafi, Mohammadhossien Shahabzadeh, Mostafa Bijani, Rahim Sharafkhani, Babak Pezeshki, Abdolmajid Ghasemian, Azizallah Dehghan

Abstract


Background: This study aimed to determine the relationships between opium use and metabolic syndrome in Fasa PERSIAN cohort data. Methods: This was an analytical cross‑sectional study conducted among participants of the first phase of the Fasa PERSIAN cohort study. A total of 10,074 participants (aged 35–70 years) were studied. The MetS was defined as per the National Cholesterol Education Program ATP III (NCEP‑ATP III) criteria. Independent sample t‑test and Chi‑square test were used for univariate analysis, and multivariate logistic regression was used to control for potential confounders and calculate odds ratios (ORs). Results: The MetS prevalence was 24.6% in the whole population (28.42% in women vs. 19.94% in men, P < 0.001). The prevalence of opium use was 23.2%. The odds of metabolic syndrome in smokers was lower than in non‑smokers (OR = 1.17%, 95% CI 1.001–1.37). Conclusions: The results of this study showed that opium consumption has an inverse relationship with metabolic syndrome. However, this study was cross‑sectional, and longitudinal studies are needed for more accurate conclusions. Opium is also a carcinogen. Therefore, its use is not recommended.

Keywords


Metabolic syndrome; opium; waist circumference; Fasa

Full Text:

PDF

References


Hajian Tilaki K. Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review. Caspian J Internal Med 2015;6:51 61.

Lim S, Kim J W, Targher G. Links between metabolic syndrome and metabolic dysfunction associated fatty liver disease. Trends Endocrinol Metab 2021;32:500 14.

Melguizo Rodríguez L, Costela Ruiz VJ, García Recio E, De Luna Bertos E, Ruiz C, Illescas Montes R. Role of vitamin D in the metabolic syndrome. Nutrients 2021;13:830. doi: 10.3390/ nu13030830.

Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018;20:1 8. doi: 10.1007/s11906 018 0812 z.

Boudreau D, Malone D, Raebel M, Fishman P, Nichols G, Feldstein A, et al. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord 2009;7:305 14.

Belete R, Ataro Z, Abdu A, Sheleme M. Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: A systematic review and meta analysis. Diabetol Metab Syndr 2021;13:1 13. doi: 10.1186/s13098 021 00641 8.

Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. The prevalence of metabolic syndrome in various populations. Am J Med Sci 2007;333:362 71.

Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis 2017;11:215 25.

Yu M, Xu CX, Zhu HH, Hu RY, Zhang J, Wang H, et al. Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: A cross sectional study. J Epidemiol 2014;24:361 9.

Moradinazar M, Najafi F, Jalilian F, Pasdar Y, Hamzeh B, Shakiba E, et al. Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic related inequalities of drug use among Iranian people: Findings from a national survey. Subst Abuse Treat Prev Policy 2020;15:1 11. doi: 10.1186/s13011 020 00279 1.

Sharifi H, Shokoohi M, Ahmad RafieiRad A, Sargolzaie Moghadam M, Haghdoost A A, Mirzazadeh A, et al. Methamphetamine use among Iranian youth: A population based knowledge, attitude, and practice study. Subst Use Misuse 2017;52:1214 21.

Wakabayashi I. Cross sectional relationship between alcohol consumption and prevalence of metabolic syndrome in Japanese men and women. J Atheroscler Thromb 2010;17:695 704.

Yousefzadeh G, Shokoohi M, Najafipour H, Eslami M, Salehi F. Association between opium use and metabolic syndrome among an urban population in Southern Iran: Results of the Kerman coronary artery disease risk factor study (KERCADRS). ARYA Atheroscler 2015;11:14 20.

Alkerwi Aa, Boutsen M, Vaillant M, Barre J, Lair M L, Albert A, et al. Alcohol consumption and the prevalence of metabolic syndrome: A meta analysis of observational studies. Atherosclerosis 2009;204:624 35.

Zhang M, Zhao J, Tong W, Wang A, Huang G, Zhang Y. Associations between metabolic syndrome and its components and alcohol drinking. Exp Clin Endocrinol Diabetes 2011;119:509 12

Chen C C, Lin W Y, Li C I, Liu C S, Li T C, Chen Y T, et al. The association of alcohol consumption with metabolic syndrome and its individual components: The Taichung community health study. Nutr Res 2012;32:24 9.

Bagheri Hosseinabadi Z, Khalili P, Hakimi H, Jalali N, Abbasifard M. Evaluation of the relationship between opioid addiction and metabolic syndrome and its components in the adult population from Rafsanjan city; A cohort study. Inflammopharmacology 2022;30:2107 16.

Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am J Epidemiol 2018;187:647 55.

Homayounfar R, Farjam M, Bahramali E, Sharafi M, Poustchi H, Malekzadeh R, et al. Cohort profile: The Fasa Adults Cohort Study (FACS): A prospective study of non communicable diseases risks. Int J Epidemiol 2023;52:e172 8.

Ramli AS, Daher AM, Noor Khan Nor Ashikin M, Mat Nasir N, Keat Ng K, Miskan M, et al. JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP ATP III and IDF criteria. BioMed Res Int 2013;2013:760963. doi: 10.1155/2013/760963.

Hirode G, Wong RJ. Trends in the prevalence of metabolic syndrome in the United States, 2011 2016. Jama 2020;323:2526 8.

Scuteri A, Laurent S, Cucca F, Cockcroft J, Cunha PG, Mañas LR, et al. Metabolic syndrome across Europe: Different clusters of risk factors. Eur J Prev Cardiol 2015;22:486 91.

Tabatabaei Malazy O, Saeedi Moghaddam S, Rezaei N, Sheidaei A, Hajipour MJ, Mahmoudi N, et al. A nationwide study of metabolic syndrome prevalence in Iran; A comparative analysis of six definitions. PloS One 2021;16:e0241926. doi: 10.1371/journal.pone. 0241926.

Enhesari A, Abasnia R, Baniasad A, Nosrati SN, Najafipour H, Najafzadeh MJ, et al. Investigating the relationship between carotid intima media thickness (cimt), opium addiction, and components of the metabolic syndrome. Addict Health 2023;15:93 9.

Soroosh D, Neamatshahi M, Zarmehri B, Nakhaee S, Mehrpour O. Drug induced prolonged corrected QT interval in patients with methadone and opium overdose. Subst Abuse Treat Prev Policy 2019;14:1 5. doi: 10.1186/s13011 019 0196 3